Leucoverdazyls as Novel Potent Inhibitors of Enterovirus Replication
Pathogens · 2024
DOI: 10.3390/pathogens13050410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Alexandrina S Volobueva und 9 weiteren Autor:innen. Beteiligte Einrichtung: St. Petersburg Pasteur Institute, 14 Mira St., St. Petersburg 197101, Russia. Hauptthemen laut MEDLINE: Virus Replication, Antiviral Agents, Enterovirus, Enterovirus Infections. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ural Branch of the Russian Academy of Sciences, Ministry of Education and Science of the Russian Federation, St. Petersburg Pasteur Institute.
Abstract (Originalsprache)
Enteroviruses (EV) are important pathogens causing human disease with various clinical manifestations. To date, treatment of enteroviral infections is mainly supportive since no vaccination or antiviral drugs are approved for their prevention or treatment. Here, we describe the antiviral properties and mechanisms of action of leucoverdazyls—novel heterocyclic compounds with antioxidant potential. The lead compound, 1a, demonstrated low cytotoxicity along with high antioxidant and virus-inhibiting activity. A viral strain resistant to 1a was selected, and the development of resistance was shown to be accompanied by mutation of virus-specific non-structural protein 2C. This resistant virus had lower fitness when grown in cell culture. Taken together, our results demonstrate high antiviral potential of leucoverdazyls as novel inhibitors of enterovirus replication and support previous evidence of an important role of 2C proteins in EV replication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- St. Petersburg Pasteur Institute, 14 Mira St., St. Petersburg 197101, Russia.
- Postovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, 22/20 S. Kovalevskoi St., Yekaterinburg 620108, Russia.
- Smorodintsev Influenza Research Institute, 15/17 Prof. Popova St., St. Petersburg 197376, Russia.
ORCID-Profile: Tatyana G Fedorchenko, Anna S Gladkikh, Olga I Kanaeva, Vladimir V Zarubaev
Förderung
- Ural Branch of the Russian Academy of Sciences
- Ministry of Education and Science of the Russian Federation
- St. Petersburg Pasteur Institute
Zitieren
APA
Volobueva, A. S., Fedorchenko, T. G., Lipunova, G. N., Valova, M. S., Sbarzaglia, V. A., Gladkikh, A. S., Kanaeva, O. I., Tolstykh, N. A., Gorshkov, A. N., & Zarubaev, V. V. (2024). Leucoverdazyls as Novel Potent Inhibitors of Enterovirus Replication. Pathogens. https://doi.org/10.3390/pathogens13050410
Vancouver
Volobueva AS, Fedorchenko TG, Lipunova GN, Valova MS, Sbarzaglia VA, Gladkikh AS, et al. Leucoverdazyls as Novel Potent Inhibitors of Enterovirus Replication. Pathogens. 2024. doi:10.3390/pathogens13050410
BibTeX
@article{Volobueva2024,
author = {Volobueva, Alexandrina S and Fedorchenko, Tatyana G and Lipunova, Galina N and Valova, Marina S and Sbarzaglia, Valeriya A and Gladkikh, Anna S and Kanaeva, Olga I and Tolstykh, Natalia A and Gorshkov, Andrey N and Zarubaev, Vladimir V},
title = {Leucoverdazyls as Novel Potent Inhibitors of Enterovirus Replication},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13050410}
}
EUVIMED